Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.
about
The value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancerPrognostic gene expression profiling in esophageal cancer: a systematic reviewNeoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatmentNEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy.Magnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.The Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer.Fiducial markers coupled with 3D PET/CT offer more accurate radiation treatment delivery for locally advanced esophageal cancer.Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancerModeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographicsEarly response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer.Imaging strategies in the management of oesophageal cancer: what's the role of MRI?Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome18F-FDG PET/CT imaging in oncologyFDG-PET parameters as prognostic factor in esophageal cancer patients: a review.Predicting response to treatment in gastroesophageal junction adenocarcinomas: combining clinical, imaging, and molecular biomarkers.The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinomaEvaluation of biodistribution and antitumor effects of (188)Re-rhk5 in a mouse model of lung cancerPET/CT and hepatic radiation injury in esophageal cancer patients.Computerized PET/CT image analysis in the evaluation of tumour response to therapy.Role of positron emission tomography in the (re-)staging of oesophageal cancer.Targeted molecular imaging in oncology: focus on radiation therapy.Current treatment approach to locally advanced esophageal cancer: is resection mandatory?Upper gastrointestinal tumours: diagnosis and staging.Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapyThe role of positron emission tomography in esophageal cancer.Biological imaging in the assessment of neoadjuvant treatment response in esophageal cancer: a new era?Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapyA phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinomaControversies in the use of endoscopic ultrasound in esophageal cancer staging.Esophageal cancer: current and emerging therapy modalities.Role of barium esophagography in patients with locally advanced esophageal cancer: evaluation of response to neoadjuvant chemoradiotherapy.The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.⁹⁹mTc-N4amG: synthesis biodistribution and imaging in breast tumor-bearing rodents.Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review.
P2860
Q26864611-AED1611E-2898-48DB-903A-710FE6D9FB5DQ28073948-D487D257-D8C9-4508-ADC3-AD446F455B5CQ28086781-7930EECD-75A4-4980-8CEE-55837C07A342Q33356751-9CCC3FDC-A7ED-41B2-9E20-EA9EE7757184Q33605656-C73B406B-627A-4282-8E87-BDCF540244FBQ33611886-6D6856EB-7E91-4903-830C-8D254C3DEF3DQ33670107-00DDFA79-7D3B-4C19-BA77-94AC4B6B4076Q33704276-143A3631-D889-4D4B-908E-D02519CF68F8Q33746586-37D272E1-92F5-4B2F-BB1A-85695577A34DQ34147279-069B1E68-0E57-4E6E-ABC3-3100CB561877Q34344204-AFB61BFB-903D-454D-9239-0BBF66BD3D2CQ34382399-0FE927FF-4BF0-4D95-A795-5418F774B655Q34390923-DA249938-4E8B-4A66-863D-53F15AD45502Q34583617-80CE7F3A-0099-4313-A2ED-24B7C9823E9BQ34980099-8D0382E7-EEA3-4CB8-88CB-62DAED99398AQ35006097-253B44B2-ABD3-4D25-BCB2-DFF508AA14B2Q35332601-7E3FA87D-3F1B-455F-B912-C75834ED44B4Q35583933-70B9895D-4DFF-4D43-800A-3C2C532E320FQ35769322-63CE2ED2-E291-4717-A458-C72A48C0EBA1Q36126676-A9F50B8C-DAEA-453A-AA92-0DA4FCFEBAA3Q36295210-3D3CFC82-6C8C-4449-9BB2-3A47449DD3FAQ36295403-C7F9696D-3B02-448F-AB01-6F01ABB8BDB4Q36510702-F666643F-B121-4170-80BA-CDB26C9AB5E0Q36528175-684B237A-938D-4260-BB65-47A6D24CC787Q36677478-6F3B3BFA-785A-4B53-AE60-28B96FE559E4Q36701795-168EE211-C613-4D1E-A3E7-A6CA4EEF1FBBQ36711287-A534AD78-DE1C-41CE-A897-08497ACE2475Q37072481-5746D1BA-1B27-4542-9A34-C4214F0A0EECQ37076612-7BE9D13D-AAAE-4A47-B956-AD9D725D0D95Q37156639-5304CF35-62C7-4066-A540-0909ECA735E8Q37161611-9B02C625-A0E1-44FE-AE21-583D4BEF367FQ37225713-413B3302-394D-4BAF-9AF3-DB7F56970857Q37226641-19D0C4FC-F8CD-4286-944C-4433174C8F4BQ37256825-59F5CE85-9395-4E5E-9DFF-D5FBD752E0D7Q37402817-F5671F05-71A9-4D8F-A4E0-BCB28E9DAB44Q37433616-831AA8C1-4C6A-4E01-8428-1280EE19098DQ37436095-380F8545-D141-4AEB-820A-A396B69E15A7Q37492159-971D477D-E197-40A4-8DC6-42AA5610A41EQ38107133-2C16D715-C59B-4034-9A3F-EA06A13621DBQ38244287-C17954CC-AC16-4D48-9B6C-93EF5EA4A326
P2860
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@ast
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@en
type
label
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@ast
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@en
prefLabel
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@ast
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@en
P2093
P1433
P1476
Esophageal cancer: CT, endosco ...... nt therapy--systematic review.
@en
P2093
Berthe L F Van Eck-Smit
Gerrit W Sloof
Henderik L van Westreenen
J Jan B van Lanschot
Jaap Stoker
John T M Plukker
Marinke Westerterp
Otto S Hoekstra
Pieter L Jager
P304
P356
10.1148/RADIOL.2363041042
P407
P577
2005-09-01T00:00:00Z